Polymyxin Resistance Testing MarketIn 2023, the polymyxin resistance testing market size is projected to be worth US$ 122.0 million. The market is projected to expand at a 6.2% CAGR during the forecast period, reaching US$ 222.5 million by 2033. Serious infections caused by Gram-negative bacteria that are resistant.
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023 lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
FLORHAM PARK, N.J., September 07, 2023 Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro
Shionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.